TREATMENT COMPRISING ORAL OR GASTRIC ADMINISTRATION OF EDARAVONE

• 收藏
• 分享

专利权人:

Treeway TW001 B.V.

发明人:

Sytske Hyke MOOLENAAR,Ronald VAN DER GEEST

申请号：

US16510518

公开号：

US20190328712A1

申请日:

2019.07.12

申请国别(地区):

US

年份:

2019

代理人:

摘要：

The invention relates to a liquid pharmaceutical composition for use in medical treatment, said liquid pharmaceutical composition being a monophasic aqueous solution of non-complexed 3-methyl-1-phenyl-2-pyrazolin-5-one (edaravone) and comprising at least 75 wt. % water and 0.2-9 mg/mL of edaravone, wherein the treatment comprises oral or gastric administration of 10-250 mL of the liquid pharmaceutical composition to provide 30-300 mg edaravone.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/